Literature DB >> 16586365

Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis.

Silva Holtfreter1, Katharina Roschack, Petra Eichler, Kristin Eske, Birte Holtfreter, Christian Kohler, Susanne Engelmann, Michael Hecker, Andreas Greinacher, Barbara M Broker.   

Abstract

Staphylococcus aureus is one of the most common causes of hospital-acquired infections. At the same time, 25% of healthy persons are symptom-free S. aureus carriers, and they have an increased risk of developing nosocomial S. aureus septicemia. Paradoxically, their prognosis is much better than that of noncarriers. We compared the antibody profiles for carriers and noncarriers toward S. aureus superantigens. In carriers, we found high titers of neutralizing antibodies specific for those superantigens that are expressed by their colonizing strain. The results show that carriage status confers strain-specific humoral immunity, which may contribute to protection during S. aureus septicemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586365     DOI: 10.1086/503048

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

Review 1.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

Review 2.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

3.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

4.  Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.

Authors:  Patricia Colque-Navarro; Gunnar Jacobsson; Rune Andersson; Jan-Ingmar Flock; Roland Möllby
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

5.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

6.  Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.

Authors:  Avanish K Varshney; Xiaobo Wang; Emily Cook; Kaushik Dutta; Matthew D Scharff; Michael J Goger; Bettina C Fries
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

Review 7.  Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.

Authors:  William E Sause; Peter T Buckley; William R Strohl; A Simon Lynch; Victor J Torres
Journal:  Trends Pharmacol Sci       Date:  2015-12-22       Impact factor: 14.819

8.  Serum capacity to neutralize superantigens does not affect the outcome of Staphylococcus aureus bacteremia.

Authors:  J Yi; J S Park; K-H Hong; S-H Lee; E-C Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-31       Impact factor: 3.267

9.  Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx.

Authors:  Nathan K Archer; Janette M Harro; Mark E Shirtliff
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

10.  Characterization of peripheral blood mononuclear cells gene expression profiles of pediatric Staphylococcus aureus persistent and non-carriers using a targeted assay.

Authors:  Elisabeth Israelsson; Damien Chaussabel; Rebecca S B Fischer; Heather C Moore; D Ashley Robinson; Jesse W Dunkle; Heather T Essigmann; Sharron Record; Eric L Brown
Journal:  Microbes Infect       Date:  2020-08-03       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.